DK0768309T3 - Fremgangsmåde til fremstilling af enantiomerisk rene imidazolforbindelser - Google Patents

Fremgangsmåde til fremstilling af enantiomerisk rene imidazolforbindelser

Info

Publication number
DK0768309T3
DK0768309T3 DK96202829T DK96202829T DK0768309T3 DK 0768309 T3 DK0768309 T3 DK 0768309T3 DK 96202829 T DK96202829 T DK 96202829T DK 96202829 T DK96202829 T DK 96202829T DK 0768309 T3 DK0768309 T3 DK 0768309T3
Authority
DK
Denmark
Prior art keywords
addition salt
acid
mixture
enantiomer
compound
Prior art date
Application number
DK96202829T
Other languages
English (en)
Inventor
Der Meij Paulus Franciscus Van
Jan-Maarten Verbeek
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of DK0768309T3 publication Critical patent/DK0768309T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK96202829T 1995-10-13 1996-10-10 Fremgangsmåde til fremstilling af enantiomerisk rene imidazolforbindelser DK0768309T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95202765 1995-10-13

Publications (1)

Publication Number Publication Date
DK0768309T3 true DK0768309T3 (da) 2002-12-09

Family

ID=8220714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96202829T DK0768309T3 (da) 1995-10-13 1996-10-10 Fremgangsmåde til fremstilling af enantiomerisk rene imidazolforbindelser

Country Status (24)

Country Link
US (1) US5663343A (da)
EP (1) EP0768309B1 (da)
JP (2) JP4590038B2 (da)
KR (1) KR100459745B1 (da)
CN (1) CN1060774C (da)
AT (1) ATE224896T1 (da)
AU (1) AU702594B2 (da)
CA (1) CA2187484C (da)
CZ (1) CZ288042B6 (da)
DE (1) DE69623900T2 (da)
DK (1) DK0768309T3 (da)
DZ (1) DZ2104A1 (da)
ES (1) ES2183908T3 (da)
HK (1) HK1000446A1 (da)
HU (1) HU226620B1 (da)
IL (1) IL119400A (da)
NO (1) NO307257B1 (da)
NZ (1) NZ299562A (da)
PT (1) PT768309E (da)
RU (1) RU2162085C2 (da)
SK (1) SK283471B6 (da)
TW (1) TW513423B (da)
UA (1) UA48947C2 (da)
ZA (1) ZA968525B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19813661A1 (de) * 1997-08-01 1999-02-04 Solvay Pharm Gmbh Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
RU2213562C2 (ru) * 2001-03-14 2003-10-10 Научно-исследовательский институт фармакологии РАМН Лекарственная композиция
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US7015333B2 (en) * 2002-11-18 2006-03-21 Solvay Pharmaceuticals B.V. Process for preparation of imidazolyl compounds
EP1424337A1 (en) * 2002-11-26 2004-06-02 Solvay Pharmaceuticals GmbH 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
ES2285407T3 (es) * 2003-01-13 2007-11-16 Dynogen Pharmaceuticals Inc. Metodo para el tratamiento de nauseas, vomitos, arcadas o cualquiera de sus combinaciones.
KR20050111318A (ko) * 2003-01-13 2005-11-24 다이노젠 파마세우티컬스, 인코포레이티드 기능성 장 질환을 치료하는 방법
CA2519379A1 (en) * 2003-04-04 2004-10-21 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
JP5156222B2 (ja) * 2006-11-28 2013-03-06 エムキュア ファーマシューティカルズ リミテッド 制吐作用化合物の新たな製造方法
GB0910373D0 (en) * 2009-06-16 2009-07-29 Filtrona Int Ltd Tabacco smoke filter
US9806720B1 (en) * 2016-10-07 2017-10-31 Analog Devices Global Compound semiconductor based inverter
WO2019222565A1 (en) 2018-05-18 2019-11-21 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7413843A (nl) * 1974-10-23 1976-04-27 Stamicarbon Optische scheiding van fenylglycine-amide.
US4463176A (en) * 1982-09-13 1984-07-31 Mead Johnson & Company Process for resolution of optical isomers
US4849527A (en) * 1982-09-13 1989-07-18 Bristol-Myers Company Process for resolution of optical isomers
PH22672A (en) * 1984-01-25 1988-11-14 Glaxo Group Ltd Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
GB8812636D0 (en) * 1988-05-27 1988-06-29 Glaxo Group Ltd Chemical compounds
US5049563A (en) * 1988-07-07 1991-09-17 Duphar International Research B.V. Annelated indoleketones with an imidazolylalkyl substituent
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
RU2041876C1 (ru) * 1993-12-29 1995-08-20 Научно-производственный центр "Фармзащита" Способ получения 1,2,3,9- тетрагидро-9-метил-3- [(2-метил-1н- имидазол-1-ил) метил]-4н- карбазол-4-она или его солей, или их гидратов, и промежуточные продукты для их синтеза

Also Published As

Publication number Publication date
DZ2104A1 (fr) 2002-07-22
JPH09183779A (ja) 1997-07-15
TW513423B (en) 2002-12-11
US5663343A (en) 1997-09-02
PT768309E (pt) 2003-02-28
DE69623900T2 (de) 2003-07-31
HU9602778D0 (en) 1996-11-28
KR100459745B1 (ko) 2005-01-26
EP0768309A1 (en) 1997-04-16
CZ294796A3 (en) 1997-05-14
HU226620B1 (en) 2009-04-28
CZ288042B6 (cs) 2001-04-11
JP2010159292A (ja) 2010-07-22
HUP9602778A3 (en) 1997-08-28
ZA968525B (en) 1997-05-20
ATE224896T1 (de) 2002-10-15
CA2187484A1 (en) 1997-04-14
JP4590038B2 (ja) 2010-12-01
NO964282D0 (no) 1996-10-09
NO964282L (no) 1997-04-14
AU6585696A (en) 1997-04-17
AU702594B2 (en) 1999-02-25
EP0768309B1 (en) 2002-09-25
SK283471B6 (sk) 2003-08-05
CA2187484C (en) 2006-09-05
IL119400A (en) 2000-02-29
IL119400A0 (en) 1997-01-10
UA48947C2 (uk) 2002-09-16
SK128796A3 (en) 1997-05-07
NO307257B1 (no) 2000-03-06
HUP9602778A2 (en) 1997-05-28
CN1060774C (zh) 2001-01-17
HK1000446A1 (en) 2003-01-10
ES2183908T3 (es) 2003-04-01
KR970021080A (ko) 1997-05-28
RU2162085C2 (ru) 2001-01-20
DE69623900D1 (de) 2002-10-31
NZ299562A (en) 1997-09-22
CN1160053A (zh) 1997-09-24

Similar Documents

Publication Publication Date Title
NO964282L (no) Fremgangsmåte for fremstilling av enantiomerisk rene imidazolylforbindelser
US5281722A (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
RU96120366A (ru) Способ получения энантиомерно чистых соединений имидазолила, энантиомерно чистая кислая аддитивная соль имидазолила и в-пироглутаминовой кислоты
EP0623104B1 (en) Profen resolution
AU701221B2 (en) Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
JP2009120611A (ja) エナンチオマーとして純粋なアゼチジン−２−カルボン酸の改良された製造方法
JP2009108079A (ja) エナンチオマーに富むｎ−アシルアゼチジン−２−カルボン酸の製造方法
AU2005306544A1 (en) Improved process for the preparation of (S)-alpha-etyl-2-oxo-1-pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
EP0220435B1 (en) A method for preparing optically active half esters
US5880296A (en) Method for preparing an optically pure benzofuran carboxylic acid and use thereof for preparing efaroxan
JP2009518335A (ja) ３−カルボキシ−２−オキソ−１−ピロリジン誘導体及びそれらの使用
PL343556A1 (en) Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
JPS6323824A (ja) 酸性α−水素を有するアミンの光学分割およびラセミ化方法
Schjelderup et al. The absolute configuration of oxyphencyclimine, a parasympatholytic drug. Syntheses of both enantiomers
US4584313A (en) (Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia
HU205594B (en) Process for producing optical isomeres of cyclopropane-carboxylic acids5
US6166224A (en) Method for racemization of optically active azetidine-2-carboxylate
EP0449011A2 (en) Stereoselective process for the preparation of 2-amino-ethanol derivatives having a central analgesic activity and intermediates thereof
ATE218125T1 (de) Synthese von chiralen 3-hydroxy-2-pyrrolidinone derivativen
ATE198189T1 (de) Synthese von optisch aktivem aminoindanol
HU202803B (en) Process for separation of optical isomers of m-phenoxymandelic acid
JPWO1999065918A1 (ja) 対掌体的に純粋な置換オキサアザ化合物、その塩、それらの製造方法